<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3ANiacin%2F32%2Fen</id>
	<title>Translations:Niacin/32/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3ANiacin%2F32%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Niacin/32/en&amp;action=history"/>
	<updated>2026-05-11T23:55:01Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://wiki.tiffa.net/w/index.php?title=Translations:Niacin/32/en&amp;diff=117732&amp;oldid=prev</id>
		<title>FuzzyBot: Importing a new version from external source</title>
		<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Niacin/32/en&amp;diff=117732&amp;oldid=prev"/>
		<updated>2024-02-20T00:42:51Z</updated>

		<summary type="html">&lt;p&gt;Importing a new version from external source&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==As lipid-modifying medication==&lt;br /&gt;
In the United States, prescription niacin, in immediate-release and slow-release forms, is used to treat primary [[hyperlipidemia]] and [[hypertriglyceridemia]]. It is used either as a monotherapy or in combination with other lipid-modifying drugs. Dosages start at 500&amp;amp;nbsp;mg/day and are often gradually increased to as high as 3000&amp;amp;nbsp;mg/day for immediate release or 2000&amp;amp;nbsp;mg/day for slow release (also referred to as sustained release) to achieve the targeted lipid changes (lower LDL-C and triglycerides, and higher HDL-C). Prescriptions in the US peaked in 2009, at 9.4{{nbsp}}million and had declined to 800{{nbsp}}thousand by 2020.&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>